Form 4: Chemours Co Director Joseph Daniel Kava Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Joseph Daniel Kava reports changes in beneficial ownership of Chemours Co common stock, including acquisition of stock units and disposal of common stock.
Summary
- On April 22, 2025, Joseph Daniel Kava, a director of Chemours Co, reported transactions involving the company's common stock.
- Kava acquired 14,096 shares of common stock units that convert one-for-one upon separation from service on the board.
- Kava also disposed of 2,886 shares of common stock.
- Following these transactions, Kava beneficially owns 16,982 shares, including stock units and dividend equivalent units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it primarily reports transactions without indicating a clear positive or negative outlook.
Positives
- The acquisition of stock units demonstrates Kava's continued investment in the company's future.
Negatives
- The disposal of 2,886 shares could be interpreted negatively, although the reason for disposal is not specified.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency to the market regarding their transactions in the company's stock.
Stakeholder Impact
- Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 04/22/2025 | Date of transaction: acquisition of stock units and disposal of common stock |
| 04/24/2025 | Date of signature for the report |
Keywords
Chemours Co, Joseph Daniel Kava, beneficial ownership, Form 4, common stock, stock units, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.